a developer of novel products to prevent and treat infectious diseases
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HWVIX | 13.40 | 0.24 | +1.82% |
Hotchkis & Wiley Sm Cp Divers Val I | |||
GQGIX | 17.94 | N/A | N/A |
GQG Partners Emerging Markets EquityInst | |||
PJDQX | 18.53 | -0.04 | -0.22% |
PGIM Jennison Rising Dividend R6 | |||
ETTGX | 109.09 | -0.60 | -0.55% |
Eaton Vance Tx-Mgd Growth 1.1 A | |||
SLARX | 29.17 | -0.17 | -0.58% |
DWS Latin America Equity Inst |
A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.
Ticker / NAME | Correlation To DVAX | 1D Price Change % | ||
---|---|---|---|---|
DVAX | 100% | +2.41% | ||
ACET - DVAX | 39% Loosely correlated | +4.14% | ||
SNDL - DVAX | 35% Loosely correlated | -4.18% | ||
AMRX - DVAX | 29% Poorly correlated | -0.47% | ||
VTRS - DVAX | 28% Poorly correlated | +0.56% | ||
COLL - DVAX | 28% Poorly correlated | +3.08% | ||
More |